Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Jubilant Life Sciences
Jubilant Life Sciences
Activities:
Manufacturing
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Distribution
Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals
Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers across Europe
Manufacturing
ON-DEMAND WEBINAR: Delivering the added dimension in Scale-up
Watch Jubilant Biosys' complimentary webinar and live Q&A, hosted in association with Manufacturing Chemist on 7 July, 2020
Delivering the added dimension in Scale-up
7 July 2020 | Webinar
Manufacturing
Jubilant Biosys begins two drug discovery facility expansions in India
The CRO has invested in expansion of the Greater Noida and Bengalaru facilities
Research & Development
Jubilant Biosys strengthens its leadership team with two key appointments
Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry
Manufacturing
Jubilant Life Sciences to sell licensed and proprietary diabetes and cardiovascular products
Has seen substantial growth in its domestic Indian market with such products
Finance
IFC makes major loan to Jubilant Pharma
To boost generics production
Subscribe now